Prospective single-arm interventional pilot study to assess a smartphone-based system for measuring and supporting adherence to medication

BMJ Open

Volumn 6, Issue 12, 2016, Pages

  Molton, James S ^a,b   Pang, Yan ^a   Wang, Zhuochun ^c   Qiu, Boqin ^c   Wu, Pei ^c   Rahman Shepherd, Afifah ^a   Ooi, Wei Tsang ^c   Paton, Nicholas I ^a,b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

adherence; Directly Observed Therapy; Smartphone

Indexed keywords

MULTIVITAMIN; RESVERATROL;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIETARY SUPPLEMENT; DIRECTLY OBSERVED THERAPY; DRUG MONITORING; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN EXPERIMENT; INGESTION; INTERVENTION STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICATION COMPLIANCE; MOBILE APPLICATION; MOBILE INTERACTIVE SUPERVISED THERAPY; NORMAL HUMAN; PATIENT COMPLIANCE; PATIENT PREFERENCE; PILL; PILOT STUDY; PROSPECTIVE STUDY; REMOTE SENSING; SMARTPHONE; STUDENT; TELETHERAPY; VIDEORECORDING; YOUNG ADULT; EVALUATION STUDY; PROCEDURES; PROGRAM EVALUATION; TELEMEDICINE; TUBERCULOSIS;

ADULT; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; PILOT PROJECTS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; SMARTPHONE; TELEMEDICINE; TUBERCULOSIS; YOUNG ADULT;

EID: 85007039822     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-014194     Document Type: Article

References (30)

1. Martin LR, Williams SL, Haskard KB, et al. The challenge of patient adherence. Ther Clin Risk Manag 2005;1:189-99 (published online first 25 Mar 2008).
2. World Health Organisation. Global Tuberculosis Report 2015: WHO, 2015. http://www.who.int/tb/publications/global-report/en/(accessed 16 Nov 2015).
3. Lee HK, Teo SSH, Barbier S, et al. The impact of direct observed therapy on daily living activities, quality of life and socioeconomic burden on patients with tuberculosis in primary care in Singapore. Proc Singapore Healthcare 2016 http://psh.sagepub.com/content/early/2016/07/22/2010105816652148.full.pdf+html
4. Sagbakken M, Bjune GA, Frich JC. Humiliation or care? A qualitative study of patients' and health professionals' experiences with tuberculosis treatment in Norway. Scand J Caring Sci 2012;26:313-23.
5. Horna-Campos OJ, Sanchez-Perez HJ, Sanchez I, et al. Public transportation and pulmonary tuberculosis, Lima, Peru. Emerg Infect Dis 2007;13:1491-3.
6. Zamudio C, Krapp F, Choi HW, et al. Public transportation and tuberculosis transmission in a high incidence setting. PLoS One 2015;10:e0115230.
7. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.
8. Gaur AH, Belzer M, Britto P, et al. Directly observed therapy (DOT) for nonadherent HIV-infected youth: lessons learned, challenges ahead. AIDS Res Human Retroviruses 2010;26:947-53.
9. McMahon JH, Medland N. 90-90-90: how do we get there? Lancet HIV 2014;1:e10-1.
10. Ericsson Mobility Report 2016: Ericsson. https://www.ericsson.com/res/docs/2016/ericsson-mobility-report-2016.pdf (accessed 11 Apr 2016).
11. Penetration rate of smartphones worldwide by country in 2015: Statista. https://www.statista.com/statistics/539395/smartphonepenetration-worldwide-by-country/(accessed 11 Nov 2016).
12. Oxlade O, Murray M. Tuberculosis and poverty: why are the poor at greater risk in India? PLoS One 2012;7:e47533.
13. Bediang G, Stoll B, Elia N, et al. SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study. Trials 2014;15:35.
14. Kunawararak P, Pongpanich S, Chantawong S, et al. Tuberculosis treatment with mobile-phone medication reminders in northern Thailand. Southeast Asian J Trop Med Public Health 2011;42:1444-51 (published online first: 2012/02/04).
15. Ammassari A, Trotta MP, Shalev N, et al. Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2011;58:e113-15.
16. da Costa TM, Barbosa BJ, Gomes e Costa DA, et al. Results of a randomized controlled trial to assess the effects of a mobile SMSbased intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages. Int J Med Inform 2012;81:257-69.
17. Hardy H, Kumar V, Doros G, et al. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDs 2011;25:153-61.
18. Mbuagbaw L, van der Kop ML, Lester RT, et al. Mobile phone text messages for improving adherence to antiretroviral therapy (ART): a protocol for an individual patient data meta-analysis of randomised trials. BMJ Open 2013;3:e002954.
19. Safren SA, Hendriksen ES, Desousa N, et al. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care 2003;15:787-93.
20. Simoni JM, Huh D, Frick PA, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr 2009;52:465-73 (published online first: 17 Nov 2009).
21. DeMaio J, Schwartz L, Cooley P, et al. The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project. Clin Infect Dis 2001;33:2082-4.
22. Gassanov MA, Feldman LJ, Sebastian A, et al. The use of videophone for directly observed therapy for the treatment of tuberculosis. Can J Public Health 2013;104:e272 (published online first: 05 July 2013).
23. Mirsaeidi M, Farshidpour M, Banks-Tripp D, et al. Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective. Eur Respir J 2015;46:871-4. (published online first: 21 Mar 2015).
24. Hoffman JA, Cunningham JR, Suleh AJ, et al. Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya. Am J Prev Med 2010;39:78-80.
25. Garfein RS, Collins K, Munoz F, et al. Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study. Int J Tuberc Lung Dis 2015;19:1057-64.
26. Gopi PG, Vasantha M, Muniyandi M, et al. Risk factors for non-adherence to directly observed treatment (DOT) in a rural tuberculosis unit, South India. Indian J Tuberc 2007;54:66-70. (published Online First: 20 June 2007).
27. Danso E, Addo IY, Ampomah IG. Patients' compliance with tuberculosis medication in Ghana: evidence from a periurban community. Adv Public Health 2015;2015:6.
28. Pandit N, Choudhary SK. A study of treatment compliance in directly observed therapy for tuberculosis. Indian J Community Med 2006;31:241.
29. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2007;(4):CD003343.
30. World Health Organization. Tuberculosis financing and funding gaps. 2013. http://www.who.int/tb/dots/funding-gaps/en/(accessed 8 Jul 2016).